BUPA ARABIA
BUPA ARABIA
As of: May 28, 2026
Company Profile
Bupa Arabia for Cooperative Insurance Company is a Saudi Joint Stock Company licensed to conduct cooperative insurance business in the Kingdom of Saudi Arabia. The Company is a mono-line insurer underwriting medical insurance only, primarily operating in the Private Medical Insurance (PMI) business. It operates through segments including Corporate (large corporations), Small and Medium Enterprises (SMEs), and individuals. The Group includes two wholly-owned subsidiaries in KSA: Bupa Arabia For Third Party Administration, which provides claims management services, and Health Horizon Medical Care Company, which provides healthcare services. Distribution of surplus from insurance operations is regulated such that shareholders receive 90% and policyholders 10%. As of March 2026, the Group is executing a proposed restructuring approved by shareholders to demerge its insurance business into a newly established wholly-owned subsidiary.
The Story
Bupa Arabia is a dominant force in the Saudi cooperative insurance sector, leveraging massive scale in the medical segment to deliver consistent underwriting profitability and high capital efficiency.
Source: Q1 2026 (2026-05-05)
Performance & Distributions
Market Pricing Multiples
Growth Story
Bupa Arabia's growth trajectory is anchored by its massive market presence, reflected in an Insurance Revenue (TTM) of SAR 19.3B and Gross Written Premiums (GWP) of SAR 7.5B. This scale positions the company as a primary beneficiary of regulatory tailwinds and expanding mandatory health insurance coverage in Saudi Arabia. The company's sustainable growth rate is established at 8.30%, supported by a strong Return on Equity (ROE) of 18.53% and a dividend payout ratio of 55.24%, demonstrating a balanced capital allocation strategy that funds organic premium expansion while consistently returning capital to shareholders.
Profitability Dynamics
The profitability profile of Bupa Arabia is defined by high-volume, disciplined underwriting, evidenced by a combined ratio of 95.41%. This performance is characterized by a high loss ratio of 95.22%, which is offset by an exceptionally lean expense ratio of 0.18%, highlighting superior operational efficiency and scale advantages. With Net Income (TTM) reaching SAR 1.1B, the company achieves an ROE of 18.53%, which substantially exceeds its estimated Cost of Equity (Ke) of 8.70% (derived from a beta of 1.0038). This spread confirms significant economic value creation, further bolstered by the steady yield from its SAR 10.7B investment asset base.
Risk & Capital Structure
Risk Factors
Bupa Arabia's risk management framework is supported by a robust balance sheet featuring Total Assets of SAR 17.5B and Total Equity of SAR 5.9B. The company carries Insurance Contract Liabilities of SAR 10.0B, which are well-matched by its highly liquid investment portfolio of SAR 10.7B. Operating within SAMA's stringent regulatory environment, the company maintains a conservative risk profile, as reflected in its market-aligned beta of 1.0038. The substantial equity cushion and conservative asset allocation mitigate underwriting volatility and potential claims inflation within the medical segment.
Research Report
Read our independent analysis →Explore BUPA ARABIA's Full Profile
Usool Research tracks BUPA ARABIA's financials, governance disclosures, valuation metrics, and more. Structured and updated from every filing.
Start Exploring → Sign up free and explore the data.